Summit Logo
Farrington and Towns
Panel _ Dale Bell


Hyatt Regency Washington 
 Capitol Hill 
The Summit is Free and Open to the Public
Like us on Facebook
Like Us 
Follow us on Twitter
Follow Us 
View our videos on YouTube View Our Videos 

"Eliminating the Disparity through advances in Treatments and Genomics, and through Government, Industry and Community Actions"  
Thursday, September 20th Opening Session Highlights:

Government Action 
8:30 AM - 1:15 PM
Kennedy Caucus Room 
Russell Senate Office Building

*The Senate Recognizes the African American Prostate Cancer Crisis is of Epidemic Proportions 
Senate Resolution S.RES.592:
Senators invited to make remarks:
Sen. John Kerry (D-MA), Introduced Senate Resolution
Sen. Daniel Akaka (D-HI), Co-Sponsor
Sen. Daniel Inouye (D-HI), Co-Sponsor
Sen. Ron Wyden (D-OR), Co-Sponsor
Sen. Ben Cardin (D-MD), Co-Sponsor
Sen. Saxby Chambliss (R-GA), Co-Sponsor

*Congressman Gregory Meeks (D-NY), Invited - Introduced Resolution in the House of Representatives

*Why the USPSTF Recommendation Against Early Detection PSA Testing Should not Apply to African Americans and Men with a Family History of Prostate Cancer
Panel Discussion: Where is the Scientific Evidence?

USPSTF statement after making its recommendation:
"Thus, no firm conclusions can be made about the balance of benefits and harms of PSA-based screening in this population."
*Moving Beyond the PSA Test Controversy Through the Evolving Impact of Genomics and Biomarkers
Genomic Health
Iris Personalized Medicine
Beckman Coulter
*New Government Actions
The Prostate Cancer Detection Research and
Education Act

Senator Barbara Boxer (Invited)
Congressman Elijah Cummings (Invited)
The National Institute of Minority Health Disparities
Outlines Initiatives
Presentations and Remarks
1:15 PM Bus Departs to:
New Samaritan Baptist Church
Bishop Michael V. Kelsey Sr., Pastor
A PHEN Church Partner
(2 Mile Trip)
Community Action
2:00 PM - 4:30 PM 

Based on attendee surveys for the 2010 and 2011 summits combined:
  • Satisfaction with summit speakers?                        91.5% very good to excellent
  • Compared to other prostate cancer conferences?     87.5% very good to excellent
  • Overall satisfaction with the summit?                          97% very good to excellent
  • Will you attend or recommend someone else attend the summit? - 100% YES